Acquisition Process of Cinterqual
ELS Solutions Group, a Portuguese multinational strategic advisory company for the Pharmaceutical Industry, has just announced the completion of the acquisition process of the commercial unit of the Portuguese company, Cinterqual, a leader in its sector of activity.
Partnership with Asian company Agape-Life MedTech Group
ELS Solutions Group, a Portuguese multinational strategic advisory company for the Pharmaceutical Industry, has just announced the conclusion of the partnership with Asian company Agape-Life MedTech Group, specialized in Asia internationalization, ensuring local quick market access & product launch for MedTech and Healthtech products, with quality and while abiding with in-country regulatory compliance.
Acquisition Process of the Brazilian Company Regulamenta
ELS Solutions Group, a Portuguese multinational strategic advisory company for the Pharmaceutical Industry, has just announced the conclusion of the acquisition process of the Brazilian company Regulamenta, specialized in developing customized solutions in the areas of Regulatory Affairs, Pharmacovigilance, Quality Assurance and Technical Processes.
Comparing the mode of action of intraocular lutein-based dyes with synthetic dyes.
Efficacy of a lutein-based dye (Phacodyne™) (...) by phacoemulsification.
Dye solutions based on lutein and zeaxanthin: in vitro and in vivo analysis of ocular toxicity profiles.
Lutein and zeaxanthin toxicity with and without brilliant blue in rabbits.
Use of lutein and zeaxanthin alone or combined (...) intraocular structures intraoperatively.
Soluble lutein in combination with brilliant blue as a new dye for chromovitrectomy.
Neurotoxic effects of MPTP on mouse cerebral cortex: (...).
Novel insights into the antioxidant role of tauroursodeoxycholic acid (...) Parkinson's disease.
Heterocellular Contacts with Mouse Brain Endothelial Cells (...).
The angiogenic factor angiopoietin-1 (...) on subventricular zone stem/progenitor cells.